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Abstract. Background/Aim: Very few studies are available
about the biological activity of 3-styrylchromones. Our
previous study demonstrated the importance of methoxy group
at 6-position of the chromone ring and hydroxyl group at 4’-
position of phenyl group in styryl moiety. As a sequel of this
study, we synthesized fourteen compounds that include eight
3-styrylchromones where methoxy group was introduced at 7-
position of chromone rings, and then evaluated their tumor-
specificity. Materials and Methods: Tumor-specificity (TS) was
calculated by relative cytotoxicity against human oral
squamous cell carcinoma cell lines versus human normal oral
cells. Apoptosis induction and growth arrest were monitored
by cell-cycle analysis. Quantitative structure–activity
relationship analysis of TS was performed with 3,167 chemical
descriptors. Results and Discussion: Two compounds, 7-
methoxy-3-[(1E)-2-phenylethenyl]-4H-1-benzopyran-4-one [7]
and 3-[(1E)-2-(4-hydroxyphenyl)ethenyl]-7-methoxy-4H-1-
benzopyran-4-one [14] showed higher tumor-specificity than
doxorubicin and 5-FU, suggesting the importance of
methoxy group in 7-position of the chromone ring. These
compounds induced the apoptosis and mitotic arrest in HSC-
2 cells. The tumor-specificity of 3-styrylchromone derivatives
were most correlated with descriptors for molecule shape
and electronic charge. The present study suggested that
modification by introducing methoxy group at 7-position,
instead at 6-position, further increased the tumor-specificity
of 3-styrylchromone.
Chromone is a two-ring backbone structure contained in many
flavonoids. 3-Chromone is a compound that has a styryl group
attached at 3-position of chromone. We previously reported 
that (E)-3-(4-hydroxystyryl)-6-methoxy-4H-chromen-4-one
(compound A) showed approximately 69-fold higher
cytotoxicity against human oral squamous cell carcinoma
(OSCC) cell lines as compared with human normal oral cells
(1). On the other hand, natural polyphenols such as tannins
and flavonoids showed only marginal tumor-specificity (2, 3).
As far as we are aware, only five studies of biological
activities of 3-styrylchromone derivatives have been reported
so far. This includes antimicrobial activity (4), anti-
picornavirus activity (5), free radical scavenging and α-
glucosidase inhibitory activity (6), apoptosis induction (7) and
tumor-specificity (1). 
Quantitative structure–activity relationship (QSAR)
analysis demonstrated the importance of methoxy group at
6-position of the chromone ring and hydroxyl group at 4’-
position of phenyl group in styryl moiety (1). As a sequel of
this study, we synthesized fourteen compounds that include
eight 3-styrylchromones where methoxy group was
introduced at 7-position of chromone ring, and then
evaluated the tumor-specificity. We first investigated their
cytotoxicity against four human oral squamous cell
carcinoma (OSCC) cells lines (Ca9-22, derived from
gingival tissue; HSC-2, HSC-3. HSC-4, derived from
tongue) and three human normal oral mesenchymal cells
[human gingival fibroblast (HGF), human periodontal
ligamental fibroblast (HPLF) and human pulp cells (HPC)],
and then performed QSAR analysis. 
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Materials and Methods
Materials. Dulbecco’s modified Eagle’s medium (DMEM) was
purchased from GIBCO BRL (Grand Island, NY, USA); fetal bovine
serum (FBS), doxorubicin, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), ribonuclease A from Sigma-
Aldrich Inc. (St. Louis, MO, USA); dimethyl sulfoxide (DMSO),
actinomycin D (FUJIFILM Wako Chem., Osaka, Japan); 5-fluorouracil
(5-FU) from Kyowa (Tokyo, Japan); 100 mm dishes from True Line
(Nippon Genetics Co., Ltd., Tokyo, Japan) and 96-well plates from
TPP (Techno Plastic Products AG, Trasadingen, Switzerland). 
Synthesis of 3-Styrylchromones. Synthesis of test compounds. 3-[(1E)-
2-Phenylethenyl]-4H-1-benzopyran-4-one [1], 3-[(1E)-2-(4-fluoro-
phenyl)ethenyl]-4H-1-benzopyran-4-one [2], 3-[(1E)-2-(4-chlorophe-
nyl)ethenyl]-4H-1-benzopyran-4-one [3], 3-[(1E)-2-(4-dimethyamino-
phenyl)ethenyl]-4H-1-benzopyran-4-one [4], 6-methoxy-3-[(1E)-2-
phenylethenyl]-4H-1-benzopyran-4-one [5], 3-[(1E)-2-(4-dimethy-
aminophenyl)ethenyl]-6-methoxy-4H-1-benzopyran-4-one [6], 7-
methoxy-3-[(1E)-2-phenylethenyl]-4H-1-benzopyran-4-one [7], 3-
[(1E)-2-(4-fluorophenyl)ethenyl]-7-methoxy-4H-1-benzopyran-4-one
[8], 3-[(1E)-2-(4-chlorophenyl)ethenyl]-7-methoxy-4H-1-benzopyran-
4-one [9], 3-[(1E)-2-(4-dimethyaminophenyl)ethenyl]-7-methoxy-4H-
1-benzopyran-4-one [10], 7-methoxy-3-[(1E)-2-(4-methoxyphenyl)
ethenyl]-4H-1-benzopyran-4-one [11], 3-[(1E)-2-(3,4-dimethoxyphenyl)
ethenyl]-7-methoxy-4H-1-benzopyran-4-one [12], 7-methoxy-3-[(1E)-
2-(3,4,5-trimethoxyphenyl)ethenyl]-4H-1-benzopyran-4-one [13] and
3-[(1E)-2-(4-hydroxyphenyl)ethenyl]-7-methoxy-4H-1-benzopyran-4-
one [14] were synthesized by Knoevenagel condensation of the
appropriate 3-formylchromone with selected phenylacetic acid
derivatives, according to previous methods (6). The compounds’
structure is shown in Figure 1. All compounds were dissolved in
DMSO at 40 mM and stored at –20˚C before use.
Cell culture. Human OSCC cell lines (Ca9-22, HSC-2, HSC-3.
HSC-4) and human normal oral mesenchymal cells (HGF, HPLF,
HPC) (established in the Meikai University) at 10-18 population
doubling levels were cultured at 37˚C in DMEM supplemented with
10% heat-inactivated FBS, 100 U/ml, penicillin G and 100 μg/ml
streptomycin sulfate under a humidified 5% CO2 atmosphere, as
described previously (7, 8). 
Assay for cytotoxic activity. Cells were inoculated at 6×103 cells/cm2
in a 96-microwell plate. After 48 h, the medium was replaced with
fresh medium containing various concentrations of 3-styrylchromones
(0.3, 0.6, 1.3, 3.1, 6.3, 12.5, 25, 50, 100, 200 or 400 μM), doxorubicin
(0.078, 0.16, 0.31, 0.63, 1.25, 2.5, 5 or 10 μM) or 5-FU (7.8, 16, 31,
63, 125, 250, 500 or 1,000 μM). Cells were incubated for 48 h and
the relative viable cell number was then determined in triplicate by
the MTT method, as described previously (7, 8). Control cells were
treated with the same amounts of DMSO and the cell damage induced
by DMSO was subtracted. The concentration of compound that
reduced the viable cell number by 50% (CC50) was determined from
the dose–response curve.
Calculation of tumor-specificity index (TS). TS was calculated by
the following equation: TS= Mean CC50 (HGF + HPLF + HPC)/
meanCC50 (Ca9-22 + HSC-2 + HSC-3 + HSC-4) (D/B) or CC50
(HGF)/CC50 (Ca9-22) [both derived from gingival tissue (9)] (C/A
in Table I). 
Calculation of potency-selectivity expression (PSE). PSE, that is the
product of tumor-specificity and cytotoxicity against tumor cells,
was calculated by the following equation: PSE={Mean CC50
(normal cells)/[mean CC50 (OSCC cell lines)]2} ×100 [as shown in
(D/B2) ×100 or (C/A2) ×100, Table I].
Cell-cycle analysis. Treated and untreated cells (approximately 106
cells) were harvested from 100 mm dish, fixed, treated with
ribonuclease A, stained with propidium iodide, filtering through cell
strainers and then subjected to cell sorting and cell-cycle analysis
with Cell Sorter Software version 2.1.2. (SONY Imaging Products
and Solution Inc., Tokyo, Japan), as described previously (8).
Estimation of CC50 values for computational analysis. The
negative log CC50 (pCC50) values for the comparison of
cytotoxicity between compounds, as described previously (8). The
mean pCC50 values for normal cells and tumor cell lines were
defined as N and T, respectively. The difference (T–N) was used
as a tumor-specificity index.
Calculation of chemical descriptors. The 3D structure of each
chemical structure (MarvinSketch 18.10.0, ChemAxon, Budapest,
Hungary) (10), was optimized by CORINA Classic (Molecular
Networks GmbH, Germany) (11) with forcefield calculations
(amber-10: EHT) in Molecular Operating Environment (MOE)
version 2019.0101 (Chemical Computing Group Inc., Quebec,
Canada) (12). The number of structural descriptors calculated from
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Figure 1. Structure of fourteen 3-styrylchromones [1-14] investigated in
this study. 
MOE and Dragon (Dragon 7 version 7.0.2 (Kode srl., Pisa, Italy)
(13) was 354 and 5,255, respectively. As a result of excluding
descriptors with a standard deviation of 0, the number of descriptors
used in this study was reduced to 307 in MOE and 2,860 in Dragon
(Total: 3,167), respectively. 
Statistical treatment. The CC50 values were expressed as mean±S.D.
of triplicate assays. The relation among cytotoxicity, tumor-specificity
index and chemical descriptors was investigated using simple
regression analyses by JMP®Pro version 14.3.0 (SAS Institute Inc.,
Cary, NC, USA) (14). The significance level was set at p<0.05.
Results
Cytotoxicity and tumor-specificity. Among fourteen synthetic 3-
styrylchromone derivatives, [7] showed the highest cytotoxicity
against four OSCC cell lines (mean CC50=0.60 μM) (B in Table
I), followed by [14] (0.65) > [8] (1.1) > [3] (5.3) > [6] (6.5) >
[4] (14.8) > [2, 12] (20.0) > [11] (21.3) > [13] (30.0) > [10]
(34.2) > [9] (70.8) > [5] (83.1) > [1] (145.6 μM). On the other
hand, [3] showed the highest cytotoxicity against three normal
oral mesenchymal cells (mean CC50=3.7 μM) (D in Table I),
followed by [8] (4.1) > [6] (6.1) > [2] (22.9) > [5] (64.0) > [13]
(91.8) > [14] (118.8) > [11] (132.6) > [4] (143.5) > [10] (156.5)
> [9] (171.6) > [7] (181.9) > [12] (183.0) > [1] (334.0 μM)
(Table I). 
When tumor-specificity (TS) was calculated by the ratio
of mean CC50 for normal oral cells to that of OSCC cells
(D/B in Table I), [7] showed the highest TS value (301.1),
followed by [14] (182.0) > [4] (9.7) > [12] (9.2) > [11] (6.2)
> [10] (4.6) > [8] (3.7) > [13] (3.1) > [9] (2.4) > [1] (2.3) >
[2] (1.1) > [6] (0.9) > [5] (0.8) > [3] (0.7).  
The derivative [7] also showed the highest PSE value
[(D/B2)x100 in Table I] (49842.4), followed by [14] (27898.1)
> [8] (346.2) > [4] (65.6) > [12] (45.9) > [11] (29.1) > [6]
(14.2) > [10] (13.4) > [3] (13.3) > [13] (10.2) > [2] (5.7) > [9]
(3.4) > [1] (1.6) > [5] (0.9). The prominent TS and PSE values
of [7, 14] were again observed when Ca9-22 and HGF (both
derived from gingival tissue) were used: 754.7, 445.0 (C/A)
and 142399.4, 69899.4 [(C/A2) ×100 in Table I], respectively.
Dose-response curves (Figure 2A and B) showed clearly that
all OSCC cells (Ca9-22, HSC-2, HSC-3, HSC-4) were more
sensitive to [7, 14] than normal oral cells (HGF, HPLF, HPC).
It should be noted that TS and PSE values of [7, 14] were
higher than doxorubicin (TS=54.9, 45.5: PSE=24953.8,
20661.2) and 5-FU (TS=16.2, 26.5; PSE=26.2, 70.5) (Table I).
Cell-cycle analysis (Figure 3) demonstrated that both [7,
14] as well as actinomycin D induced subG1 population,
suggesting the apoptosis induction. It should be noted that
[7, 14], but not actinomycin D, induced G2+M phase arrest.
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Table I. Cytotoxic activity of fourteen 3-styrylchromones [1-14] against human oral squamous cell carcinoma (OSCC) cell lines and human oral
normal cells. Each value represents the mean of triplicate determinations. Two sets of tumor-specificity index (TS) and potency-selectivity expression
(PSE) values were determined as described in Materials and Methods.
                                                                                         CC50 (μM)
            Human oral squamous cell carcinoma cell lines                      Human normal oral cells
                                                                                                                                                                                           TS PSE
          Ca9-22    HSC-2    HSC-3     HSC-4     mean      SD       HGF      HPLF      HPC       mean         SD                                                         
              A                                                         B                       C                                         D                          D/B          C/A        (D/B2)      (C/A2)
                                                                                                                                                                                                                    ×100         ×100
                                                                                                                                                                                                                                          
1           78.3     152.3      150.7       201.0     145.6      50.5     380.3    387.3      234.3      334.0        86.4          2.3          4.9             1.6              6.2 
2           19.6       17.0        23.6         19.6       20.0        2.7       21.6      23.6        23.4        22.9          1.1          1.1          1.1             5.7              5.6 
3             4.7         5.9          4.6           6.1         5.3        0.8         5.0        3.1          3.1          3.7          1.1          0.7          1.1           13.3            22.7 
4             9.2         5.5        20.0         24.5       14.8        8.9     400.0        3.4        27.0      143.5      222.5          9.7        43.5           65.6          472.6 
5         102.3     127.0        91.3         11.7       83.1      49.9     147.3      21.6        23.0        64.0        72.2          0.8          1.4             0.9              1.4 
6             7.5         3.1          6.2           9.4         6.5        2.6         6.8        5.2          6.3          6.1          0.8          0.9          0.9           14.2             11.9 
7             0.53       0.50        0.38         1.00       0.6        0.27   400.0      24.5      121.3      181.9      195.0      301.1      754.7     49842.4    142399.4 
8             1.09       0.93        0.79         1.51       1.1        0.31       5.9        3.1          3.1          4.1          1.6          3.7          5.4         346.2          493.6 
9           50.0         7.3        54.8       171.0       70.8      70.1     400.0      68.8        46.0      171.6      198.1          2.4          8.0             3.4            16.0 
10         24.3       11.1        23.2         78.2       34.2      29.9     400.0      15.9        53.6      156.5      211.7          4.6        16.4           13.4            67.6 
11         34.3         3.1        26.2         21.8       21.3      13.2     383.3        3.4        10.9      132.6      217.2          6.2         11.2           29.1            32.5 
12         21.0       18.6        21.3         19.0       20.0        1.4     400.0      32.9      116.0      183.0      192.5          9.2        19.0           45.9            90.7 
13         18.7       46.3        25.9         29.2       30.0      11.7       82.1    113.3        80.0        91.8        18.7          3.1          4.4           10.2            23.4 
14           0.64       1.12        0.32         0.54       0.65      0.34   283.3      33.0        40.0      118.8      142.6      182.0      445.0     27898.1      69899.4 
DXR      0.22       0.12        0.29         0.09       0.18      0.08     10.0      10.0          9.2          9.7          0.3        54.9        45.5     24953.8      20661.2 
5-FU    37.7     187.7        14.2           7.8       61.8      84.9   1000.0  1000.0    1000.0    1000.0          0.0        16.2        26.5           26.2            70.5 
DXR: Doxorubicin; 5-FU: fluorouracil; Ca9-22: derived from gingival tissue; HSC-2, HSC-3 and HSC-4: derived from tongue. 
Computational analysis. QSAR analysis of cytotoxicity and
tumor-specificity of fourteen 3-styrylchromone derivatives
[1-14] were next performed. Since a significant correlation
(p<0.05) was found between cytotoxicity against tumor and
normal cells, and TS with 2, 12 and 69 chemical descriptors
(data not shown), top two or six chemical descriptors were
chosen for QSAR analysis (Figures 4, 5 and 6, and Table II).
The cytotoxicity of 3-styrylchromone derivatives [1-14]
against human OSCC cell lines was correlated positively
with PJI3 (3D shape and size) (r2=0.470, p=0.0068) while
negatively with CIC1 (topological shape) (r2=0.307,
p=0.0398) (Figure 4)
The cytotoxicity of 3-styrylchromones [1-14] against
normal oral cells was correlated positively with Petitjean
(topological shape and size) (r2=0.373, p=0.0203),
SpMAD_AEA(dm) (topological shape and dipole moment)
(r2=0.363, p=0.0226), BIC0 (topological shape) (r2=0.321,
p=0.0346) and JGI8 (topological shape and electric state)
(r2=0.306, p=0.0402), while negatively with MATS4s
(topological shape and electric state) (r2=0.321, p=0.0348)
and MATS4e (topological shape and electric state) (r2=0.319,
p=0.0355) (Figure 5). 
The TS of fourteen 3-styrylchromones [1-14] was
correlated positively with MATS4e (topological shape and
electric state) (r2=0.414, p=0.0131), H8s (3D shape)
(r2=0.404, p=0.0145), MNDO_LUMO (energy of the
LUMO) (r2=0.391, p=0.0168), and H8e (3D shape and
electric state) (r2=0.343, p=0.0276), while negatively with
AROM (aromaticity index) (r2=0.349, p=0.0259), FASA_H
(3D shape, size and partial charges) (r2=0.346, p=0.0269)
(Figure 6).
Tumor-specificity of [1-14] was reduced by the presence
of methoxy group at R1 (6-position of chromone ring), but
increased by the presence of methoxy group at R2 (7-
position of chromone ring) (Figure 7). 
Discussion
The present study demonstrated that compounds 7-methoxy-3-
[(1E)-2-phenylethenyl]-4H-1-benzopyran-4-one [7] (TS=301.1
in D/B, 754.7 in C/A; PSE= 49842.4 in 100 × D/B2, 142399.4
in 100 × C/A2) and 3-[(1E)-2-(4-hydroxyphenyl)ethenyl]-7-
methoxy-4H-1-benzopyran-4-one [14] (TS=182.0, 445.0;
PSE=27898.1, 69899.4) showed higher tumor-specificity than
with doxorubicin (TS=54.9, 45.5; PSE=24953.8, 20661.2) and
5-FU (TS=16.2, 26.5; 26.2, 70.5) (Table I). This suggests the
antitumor potential of [7, 14].
We previously reported that (E)-3-(4-hydroxystyryl)-6-
methoxy-4H-chromen-4-one (compound A) that have
methoxy group at 6-position of the chromone ring and
hydroxyl group at 4’-position of phenyl group in styryl
moiety showed excellent tumor-specificity [TS=69.0 in D/B,
31.9 in C/A) (1); PSE=3,450 in 100 × D/B2] (7). We found
that [14] (TS=182.0) with methoxy group at 7-position
showed higher tumor-specificity than compound A with
methoxy group at 6-position (TS=69.0) (1). Similarly, the
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Figure 2. Cytotoxicity of compounds [7, 14] against four human OSCC cell lines, Ca9-22 (●), HSC-2 (■), HSC-3 (▲) and HSC-4) (◆), and three
human normal mesenchymal oral cells, HGF (●), HPLF (■) and HPC (▲). Cells were incubated for 48 h without (control) or with the indicated
concentrations of [7] (A) or [14] (B), and cell viability was determined by MTT method, and expressed as percentage of control. Each value
represents the mean±S.D. of triplicate assays. 
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Figure 3. Effect of [7, 14] on cell-cycle distribution in HSC-2 cells. HSC-2 cells were incubated for 24 h with the indicated concentrations of [7],
[14] or 1 μM actinomycin D (Act D) as a positive control and then assessed for cell-cycle distribution by a cell sorter. 
Figure 4. Two chemical descriptors that showed higher correlation with cytotoxicity of fourteen 3-styrylchromones [1-14] against OSCC cells. The
mean negative log CC50 values (T) against tumor cells were plotted. CC50: concentration of compound that reduced the viable cell number by 50%.
PJI3 (3D shape and size) (r2=0.470, p=0.0068) and CIC1 (topological shape) (r2=0.307, p=0.0398).
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Figure 5. Top six chemical descriptors that showed higher correlation with cytotoxicity of fourteen 3-styrylchromones [1-14] against normal oral
cells. The mean negative log CC50 values (N) against normal cells were plotted. Top six chemical descriptors were: Petitjean (topological shape
and size) (r2=0.373, p=0.0203), SpMAD_AEA(dm) (topological shape and dipole moment) (r2=0.363, p=0.0226), BIC0 (topological shape)
(r2=0.321, p=0.0346), MATS4s (topological shape and electric state) (r2=0.321, p=0.0348), MATS4e (topological shape and electric state)
(r2=0.319, p=0.0355) and JGI8 (topological shape and electric state) (r2=0.306, p=0.0402). 
Figure 6. Top six chemical descriptors that showed higher correlation with tumor-specificity of fourteen 3-styrylchromones [1-14]. The mean negative
log TS values (T-N) were plotted. Top six chemical descriptors were: MATS4e (topological shape and electric state) (r2=0.414, p=0.0131), H8s
(3D shape) (r2=0.404, p=0.0145), MNDO_LUMO (energy of the LUMO) (r2=0.391, p=0.0168), AROM (aromaticity index) (r2=0.349, p=0.0259),
FASA_H (3D shape, size and partial charges) (r2=0.346, p=0.0269) and H8e (3D shape and electric state) (r2=0.343, p=0.0276).
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Table II. Properties of descriptors that significantly correlated with cytotoxicity of fourteen 3-styrylchromones [1-14] against tumor cells (T) and
normal cells (N), and tumor-specificity (T-N).
                    Descriptor               Source                      Meaning                                     Category                                             Explanation
T                       PJI3                   Dragon             3D shape and size                 Geometrical descriptors                      3D Petitjean shape index
                        CIC1                  Dragon              Topological shape                    Information indices          Complementary Information Content index 
                                                                                                                                                                               (neighborhood symmetry of 1-order)
N                   petitjean                 MOE               Topological shape               Adjacency and Distance          Value of (diameter - radius)/diameter.
                                                                                     and size                             Matrix Descriptors
            SpMAD_AEA(dm)       Dragon          Topological shape and             Edge adjacency indices               Spectral mean absolute deviation 
                                                                               dipole moment                                                                          from augmented edge adjacency 
                                                                                                                                                                                  mat. weighted by dipole moment
                        BIC0                  Dragon              Topological shape                    Information indices                   Bond Information Content index 
                                                                                                                                                                               (neighborhood symmetry of 0-order)
                     MATS4s               Dragon          Topological shape and                2D autocorrelations                    Moran autocorrelation of lag 4 
                                                                                 electric state                                                                                       weighted by I-state
                     MATS4e               Dragon          Topological shape and                2D autocorrelations                    Moran autocorrelation of lag 4 
                                                                                 electric state                                                                      weighted by Sanderson electronegativity
                        JGI8                   Dragon          Topological shape and                2D autocorrelations            Mean topological charge index of order 8
                                                                                 electric state
T-N               MATS4e               Dragon          Topological shape and                2D autocorrelations                    Moran autocorrelation of lag 4 
                                                                                 electric state                                                                      weighted by Sanderson electronegativity
                         H8s                   Dragon                     3D shape                         GETAWAY descriptors       H autocorrelation of lag 8/weighted by I-state
               MNDO_LUMO           MOE            Energy of the LUMO                MOPAC Descriptors         The energy (eV) of the Lowest Unoccupied 
                                                                                                                                                                             Molecular Orbital calculated using the 
                                                                                                                                                                                   MNDO Hamiltonian [MOPAC].
                      AROM                 Dragon              Aromaticity index                 Geometrical descriptors            The Aromaticity (AROM) is derived 
                                                                                                                                                                                   from the scheme of the general 
                                                                                                                                                                                             aromaticity indices.
                     FASA_H                 MOE              3D shape, size and              Conformation Dependent                Fractional ASA_H calculated 
                                                                                partial charges                       Charge Descriptors                                 as ASA_H/ASA.
                         H8e                   Dragon                 3D shape and                    GETAWAY descriptors              H autocorrelation of lag 8/weighted 
                                                                                 electric state                                                                              by Sanderson electronegativity
Figure 7. Correlation between T-N and the presence of OCH3 group in R1 and R2. Statistical comparison between the means of two groups was
performed by Wilcoxon exact test. The significance level was set at p<0.05.
most potent compound [7] (TS=301.1) has methoxy group at
7-position and non-substituted styryl moiety, and replacing
the methoxy group to 6-position yielded [5] with much
reduced tumor-specificity (TS=0.8). This suggests that the
introduction of methoxy group at 7-position is involved in
the elevation of tumor-specificity.
QSAR analysis demonstrated that the cytotoxicity of 3-
styrylchromone derivatives [1-14] against OSCC cell lines
was correlated positively with 3D and topological shape,
and size (Figure 4). Their cytotoxicity against normal cells
was correlated with topological shape and size, dipole
moment and electric state (Figure 5). Their TS was
correlated with 3D and topological shape, size, electric
state, energy of the LUMO, aromaticity index and partial
charges (Figure 6).
The present study also demonstrated that both [7, 14]
produced a subG1 cell population (a marker of apoptosis),
and induced the accumulation at G2+M phase cells in human
oral squamous cell carcinoma cell line HSC-2 (Figure 3). It
has been reported recently that 4’-methoxy-2-styrylchromone
induced mitotic arrest in human tumor (human Caucasian
breast adenocarcinoma MCF-7 and human lung
adenocarcinoma NCI-H460) cell lines, in a similar fashion
to paclitaxel (15). It remains to be investigated whether
mitotic arrest is common phenomenon after treatment with
either 2-styrylchromon or 3-styrylchromone.
It should be noted that both [7, 14] induced apoptosis
(subG1 population) of HSC-2 cells to comparable extent that
attained by actinomycin D, positive control used in this study
(16). Induction of both apoptosis and G2+M arrest may
further potentiate the antitumor potential.  
We found that TS value (D/B in Table I) of two 3-
styrylchromones [7, 14] (TS=301.1, 182.0) is much higher
than the maximum TS values of 3-(N-cyclicamino)chromones
(TS=12.3) (17), pyrano[4,3-b]chromones (TS=47.8) (18), 2-
arylazolylchromones and 2-triazolylchromones (TS=21.2) (19)
and 2-styrylchromones (TS=89.1) (20). This suggests that [7,
14] can be lead compounds for designing new types of
anticancer drugs. 
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